Structural Characterization of 4-1BB-Galectin-9 Complexes
Structural Characterization of 4-1BB-Galectin-9 Complexes
批准号:
8679808
负责人:
Michael Croft
金额:
$8.85万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-07-01 至 2016-06-30
关键词:
AgonistAnimal LectinsAnti-Inflammatory AgentsAnti-inflammatoryAntibodiesApoptosisArchitectureAutoimmune DiseasesAutoimmune ProcessBindingBiological AssayC-terminalCarbohydratesCaspaseCell CommunicationCell DeathCell membraneCell surfaceCellsClinicalClinical TrialsCommunicationComplexCrystallizationCysteine-Rich DomainDataDevelopmentDiseaseDisease modelDrug ControlsElectron MicroscopyEndothelial CellsEpithelial CellsEvaluationFamilyFamily memberFlowersGalactose Binding LectinGovernmentHomeostasisHumanHypersensitivityImmuneImmune systemImmunologyIndividualInflammationInflammatoryInstitutesInterventionLearningLengthLigand BindingLigandsLigationLinkMammalsMapsMeasuresMembraneN-terminalNegative StainingOrganOutcomePathway interactionsPersonsProtein FamilyProtein-Serine-Threonine KinasesProteinsReagentRegulationResolutionShapesSideSignal TransductionSignal Transduction PathwaySite-Directed MutagenesisStimulusStromal CellsStructureSystemT-Cell ActivationTNFRSF1A geneTNFRSF1B geneTNFRSF5 geneTumor Necrosis Factor ReceptorTumor Necrosis Factor-BetaTumor Necrosis Factor-alphaVariantX-Ray Crystallographybasebonecancer immunotherapycell typecytokinedisulfide bondextracellularin vivoinhibitor/antagonistinsightmembermonomernovelparticlepre-clinicalpublic health relevancereceptorreconstructionthree dimensional structure
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Proteins in the tumor necrosis factor receptor superfamilies' (TNFSF/TNFRSF) are expressed on cells of the immune system, as well as on non-lymphoid structural cells such as stromal, epithelial, and endothelial cells. They have a broad range of activities in regulating cell-cell communication in many organs. TNF family molecules have canonical TNF homology domains with ¿-sandwich jelly-roll structures, and TNFR family molecules contain variable numbers of ligand-binding extracellular cysteine-rich domains (CRDs). TNFSF are active largely as cell-surface or soluble homotrimers, and the crystallized complexes of 11 interactions solved to date show that the trimers engage 3 individual TNFRSF monomers. Whether a single trimeric complex is sufficient for cellular activation is not known, but oligomers of the basic trimer may also need to form for maximal signaling. How each TNFRSF forms a functional signaling unit likely differs due to variations in the ligand structures as well as how they are recognized by the receptors. TNFSF trimers have been subdivided into 3 groups: conventional/bell-shaped, EF-disulfide bond linked/globular, and divergent/blooming flower-like. These structures have been suggested to regulate the spacing between TNFRSF monomers when binding their ligands on the cell membrane which has been theorized to control the intracellular recruitment of adaptors that link to signal transduction pathways. We have studied 4-1BBL (CD137L/TNFSF9), which was recently crystallized and shown to exert the most open structure of any of the divergent/blooming flower-like TNFSF molecules. This suggests it may not be able to cluster 3 monomeric 4-1BB (CD137/TNFRSF9) molecules as effectively as other TNFSF proteins, or may not efficiently allow oligomers to form. Therefore 4-1BBL might need additional co-receptor proteins to engage 4-1BB to aggregate into a fully functional signaling unit. We have now discovered that 4-1BB interacts with Galectin-9 (Gal-9), a member of a family of animal lectins that interact with proteins in part via carbohydrates. In functional studies of immune cells, and in disease models in vivo, we have found that Gal-9 is required for the activity of 4-1BB. We hypothesize that Gal-9 is a co-receptor protein for 4-1BB that enables 4-1BB monomers to complex into a functional signaling unit. We will determine the three dimensional structures of human 4-1BB complexed with Gal-9, and of 4-1BB complexed with 4-1BBL, using X-ray crystallography, and also attempt to crystallize a ternary complex of all three molecules. These studies will define a new paradigm for structural interaction in the TNFR family.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
TWEAK and Skin Inflammation
-
批准号:10400699
-
项目类别:
-
资助金额:$39.2万
-
财政年份:2018
-
负责人:Michael Croft
-
依托单位:
A Treg cell-intrinsic CTLA4-PKC-eta signaling pathway mediating contact-dependent suppression of tumor immunity: A novel target for cancer immunotherapy
-
批准号:10531229
-
项目类别:
-
资助金额:$51.26万
-
财政年份:2018
-
负责人:Michael Croft
-
依托单位:
Immune Regulation by Deubiquitination
-
批准号:9982199
-
项目类别:
-
资助金额:$45.0万
-
财政年份:2018
-
负责人:Michael Croft
-
依托单位:
A Treg cell-intrinsic CTLA4-PKC-eta signaling pathway mediating contact-dependent suppression of tumor immunity: A novel target for cancer immunotherapy
-
批准号:10053328
-
项目类别:
-
资助金额:$52.31万
-
财政年份:2018
-
负责人:Michael Croft
-
依托单位:
TWEAK and Skin Inflammation
-
批准号:9910059
-
项目类别:
-
资助金额:$39.6万
-
财政年份:2018
-
负责人:Michael Croft
-
依托单位:
A Treg cell-intrinsic CTLA4-PKC-eta signaling pathway mediating contact-dependent suppression of tumor immunity: A novel target for cancer immunotherapy
-
批准号:10310411
-
项目类别:
-
资助金额:$51.26万
-
财政年份:2018
-
负责人:Michael Croft
-
依托单位:
TWEAK and Skin Inflammation
-
批准号:10152528
-
项目类别:
-
资助金额:$38.41万
-
财政年份:2018
-
负责人:Michael Croft
-
依托单位:
Immune Regulation by Deubiquitination
-
批准号:9788250
-
项目类别:
-
资助金额:$45.0万
-
财政年份:2018
-
负责人:Michael Croft
-
依托单位:
Training in Immunological Mechanisms
-
批准号:9321444
-
项目类别:
-
资助金额:$33.47万
-
财政年份:2016
-
负责人:Michael Croft
-
依托单位:
Training in Immunological Mechanisms
-
批准号:10675443
-
项目类别:
-
资助金额:$25.73万
-
财政年份:2016
-
负责人:Michael Croft
-
依托单位:
Training in Immunological Mechanisms
-
批准号:10269804
-
项目类别:
-
资助金额:$37.53万
-
财政年份:2016
-
负责人:Michael Croft
-
依托单位:
Training in Immunological Mechanisms
-
批准号:10458735
-
项目类别:
-
资助金额:$33.27万
-
财政年份:2016
-
负责人:Michael Croft
-
依托单位:
Novel PTPRD interaction Controlling T cell Responsiveness
-
批准号:9077779
-
项目类别:
-
资助金额:$26.55万
-
财政年份:2016
-
负责人:Michael Croft
-
依托单位:
Control of Airway Tolerance
-
批准号:8577804
-
项目类别:
-
资助金额:$41.6万
-
财政年份:2013
-
负责人:Michael Croft
-
依托单位:
Control of Airway Tolerance
-
批准号:8661698
-
项目类别:
-
资助金额:$44.25万
-
财政年份:2013
-
负责人:Michael Croft
-
依托单位:
Novel costimulatory pathways required for T cell regulation
-
批准号:8495230
-
项目类别:
-
资助金额:$43.81万
-
财政年份:2013
-
负责人:Michael Croft
-
依托单位:
Control of Airway Tolerance
-
批准号:9267076
-
项目类别:
-
资助金额:$44.25万
-
财政年份:2013
-
负责人:Michael Croft
-
依托单位:
Control of Airway Tolerance
-
批准号:9054041
-
项目类别:
-
资助金额:$44.25万
-
财政年份:2013
-
负责人:Michael Croft
-
依托单位:
Control of Airway Tolerance
-
批准号:8839196
-
项目类别:
-
资助金额:$44.25万
-
财政年份:2013
-
负责人:Michael Croft
-
依托单位:
Novel costimulatory pathways required for T cell regulation
-
批准号:8377924
-
项目类别:
-
资助金额:$46.61万
-
财政年份:2012
-
负责人:Michael Croft
-
依托单位:
海外基金